longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Hinge Health

HNGE

92.3600.09% ( +0.080 )
Trading: Sep 24, 12:45:36 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 FY2026 EarningsQ2 FY26 performance significantly beat consensus estimates across all key financial metrics, highlighted by revenue of $212.8M (vs. $201.5M expected) and a non-GAAP EPS of $0.59 (vs. $0.62 expected). Revenue grew 53% YoY, driven by high member conversion and client expansion to 2,929. Free cash flow reached $99.6M, far exceeding the $67.8M low-end consensus, while full-year revenue guidance was raised to $858M at the midpoint, signaling robust momentum into H2.

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Hinge Health(HNGE) the Revenue is 212.82 M (+53%), Beat estimate;the EBIT is 61.51 M (+135.7%), Beat estimate;the EPS is 0.52 (+104%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.21B53.00%
0.20B44.85%
+0.01B8.15%
EBITExceed expectations
0.06B135.67%
0.05B96.43%
+0.01B39.24%
EPSExceed expectations
0.52103.97%
0.3856102.94%
+0.13441.03%

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf